Liver Transplantation in the Philippines: Light at the End of the Tunnel.

Transplantation proceedings Pub Date : 2024-12-01 Epub Date: 2024-11-26 DOI:10.1016/j.transproceed.2024.11.009
Siegfredo R Paloyo, Ferri P David-Paloyo, Rose Marie R Liquete, Enrique T Ona
{"title":"Liver Transplantation in the Philippines: Light at the End of the Tunnel.","authors":"Siegfredo R Paloyo, Ferri P David-Paloyo, Rose Marie R Liquete, Enrique T Ona","doi":"10.1016/j.transproceed.2024.11.009","DOIUrl":null,"url":null,"abstract":"<p><p>End-stage liver disease is arguably one of the leading burdensome diseases among developing countries such as the Philippines. Although liver transplantation is considered the treatment of choice for decompensated cirrhosis, the establishment of a robust transplant program locally has been protracted as numerous obstacles continue to plague our transplant landscape. Issues on cost, options of having the transplant done overseas, and low rates of deceased donation are some of the difficulties that hamper our program's progress and development. In this study, we aim to present our experience and discuss hurdles, describing the current status of liver transplantation in the country. Herein we report our initial 68 liver transplants covering 35 years. A retrospective review was performed including all transplants done in 4 active transplant centers from August 1988 to December 2023. Recipients were mostly male patients (69%) with hepatitis B as the most common (32%) primary liver disease. Deceased donor liver transplant was more common (65%) with recipients having a median Model for End-Stage Liver Disease (MELD) score of 22. Among living donor liver transplants, 58% of the grafts were from the left lateral segment. Outcomes can be divided into two eras, with the first era (1988-2010) having a 1-year graft survival of only 25%. The second era (2011-present) was marked with surgical refinements and advancing knowledge, improving 1-year graft survival to 64% and 67% for adult and pediatric transplants, respectively. Indeed, the establishment of a liver transplant program requires a team approach and most fundamentally, full training in liver transplantation and the management of its complications. Optimal patient selection remains essential in achieving excellent survival outcomes. Last, Filipinos with liver cirrhosis now have an opportunity for a significant improvement in their quality of life by undergoing transplantation in their native country.</p>","PeriodicalId":94258,"journal":{"name":"Transplantation proceedings","volume":" ","pages":"2178-2182"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.transproceed.2024.11.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

End-stage liver disease is arguably one of the leading burdensome diseases among developing countries such as the Philippines. Although liver transplantation is considered the treatment of choice for decompensated cirrhosis, the establishment of a robust transplant program locally has been protracted as numerous obstacles continue to plague our transplant landscape. Issues on cost, options of having the transplant done overseas, and low rates of deceased donation are some of the difficulties that hamper our program's progress and development. In this study, we aim to present our experience and discuss hurdles, describing the current status of liver transplantation in the country. Herein we report our initial 68 liver transplants covering 35 years. A retrospective review was performed including all transplants done in 4 active transplant centers from August 1988 to December 2023. Recipients were mostly male patients (69%) with hepatitis B as the most common (32%) primary liver disease. Deceased donor liver transplant was more common (65%) with recipients having a median Model for End-Stage Liver Disease (MELD) score of 22. Among living donor liver transplants, 58% of the grafts were from the left lateral segment. Outcomes can be divided into two eras, with the first era (1988-2010) having a 1-year graft survival of only 25%. The second era (2011-present) was marked with surgical refinements and advancing knowledge, improving 1-year graft survival to 64% and 67% for adult and pediatric transplants, respectively. Indeed, the establishment of a liver transplant program requires a team approach and most fundamentally, full training in liver transplantation and the management of its complications. Optimal patient selection remains essential in achieving excellent survival outcomes. Last, Filipinos with liver cirrhosis now have an opportunity for a significant improvement in their quality of life by undergoing transplantation in their native country.

菲律宾的肝脏移植手术:隧道尽头的曙光
终末期肝病可以说是菲律宾等发展中国家的主要负担疾病之一。虽然肝移植被认为是治疗失代偿期肝硬化的首选方法,但在当地建立健全的移植项目却一直旷日持久,因为众多障碍一直困扰着我们的移植事业。成本问题、选择在海外进行移植以及死者捐献率低都是阻碍我们项目进展和发展的一些困难。在本研究中,我们旨在介绍我们的经验,讨论存在的障碍,描述我国肝移植的现状。在此,我们报告了我们最初的 68 例肝移植手术,时间跨度长达 35 年。我们对 1988 年 8 月至 2023 年 12 月期间在 4 个活跃的移植中心进行的所有移植手术进行了回顾性审查。受者多为男性患者(69%),乙型肝炎是最常见的原发性肝病(32%)。死亡供体肝移植更常见(65%),受者的终末期肝病模型(MELD)中位数为 22 分。在活体肝移植中,58%的移植物来自左侧肝段。结果可分为两个时代,第一个时代(1988-2010年)的1年移植物存活率仅为25%。第二个时代(2011年至今)的特点是手术的改进和知识的进步,成人和儿童移植手术的1年存活率分别提高到64%和67%。事实上,肝移植项目的建立需要团队合作,最根本的是需要接受肝移植及其并发症处理方面的全面培训。最佳的患者选择仍然是取得良好生存结果的关键。最后,患有肝硬化的菲律宾人现在有机会在自己的祖国接受移植手术,从而显著改善生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信